Pirruccello S, Barranger J A, Barton N W, Brady R O, Ginns E I
Biochem Med. 1984 Feb;31(1):73-9. doi: 10.1016/0006-2944(84)90061-9.
Cross-reacting material (CRM) to human beta-D-glucocerebrosidase has been demonstrated in circulating mononuclear white blood cells of normal controls, heterozygotes, and homozygotes for Gaucher's disease. The major CRM in both normal and mutant cells corresponds to a species with Mr approximately equal to 63,000 Da. Traces of CRM at Mr approximately equal to 61,000 and 56,000 Da are also present. In contrast, the CRM in other human tissues differs markedly from that found in circulating mononuclear cells. Evidence is presented to support the hypothesis that the CRM found in white cells is a precursor of the enzyme. The significance of these results is discussed in relation to the problems of subtype determination and heterozygote detection.
在戈谢病的正常对照者、杂合子和纯合子的循环单核白细胞中已证实存在与人β-D-葡糖脑苷脂酶发生交叉反应的物质(CRM)。正常细胞和突变细胞中的主要CRM对应于一种分子量约为63,000道尔顿的物质。还存在分子量约为61,000和56,000道尔顿的痕量CRM。相比之下,其他人体组织中的CRM与循环单核细胞中的CRM明显不同。有证据支持白细胞中发现的CRM是该酶前体的假说。结合亚型确定和杂合子检测问题讨论了这些结果的意义。